Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.
April 30, 2019adminConsumer, NewsmakersComments Off on American Premium Water Corp. (OTC: HIPH) Announces Sponsorship of NFL Draft Party Hosted by Star New York Jets Running Back Le’Veon Bell
The event further establishes LALPINA CBD’s connection to professional athletes as the Company looks to penetrate the $30 billion US fitness market PLAYA VISTA, Apr 25, 2019 – American Premium Water Corporation(OTC: HIPH) announces that […]
Upon closing of pending acquisitions, the Company will operate a total of 14 dispensaries within Colorado- The acquisitions are part of MMT’s strategy aimed at creating an integrated operation, to include proven and profitable cultivation, […]
FSD Pharma Announces Strategic Investment in Huge Shops – Huge Shops forms alliance with Coffee Time’s parent company Chairman’s Brands to establish retail distribution network – TORONTO—FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTCQB: […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.